ANXA1 and cancer: The protein was originally reported for its anti-phospholipase activity following glucocorticoid induction however, subsequent studies from our group and others showed that ANXA1 possesses a wide range of physiological and pathological functions [11–16], some of whom correlate to cancer development [17–21].